March 22, 2018 6:17 PM ET

Healthcare Providers and Services

Company Overview of InfuSystem Holdings Inc.

Company Overview

InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home i...

31700 Research Park Drive

Madison Heights, MI 48071

United States

Founded in 2005



Key Executives for InfuSystem Holdings Inc.

Executive VP, COO, Compliance Officer, Privacy Officer & Member of Office - President
Age: 57
Total Annual Compensation: $321.3K
Compensation as of Fiscal Year 2016.

InfuSystem Holdings Inc. Key Developments

InfuSystem Holdings, Inc Announces Executive Changes

InfuSystem Holdings Inc. announced that its interim chief financial officer, Christopher Downs, has informed the Company of his decision to resign his position with the company, effective March 31, 2018. Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company's financial performance. Following Mr. Downs's departure, Trent Smith, CPA, the company's executive vice president, corporate controller and chief accounting officer will assume Mr. Downs's responsibilities as treasurer and principal financial officer. The Company will immediately begin a search for a new chief financial officer. Mr. Downs has agreed to continue in his position as interim chief financial officer until the end of the current quarter in order to assist the Company with the preparation and reporting of its annual financial statements.

InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit

InfuSystem Holdings Inc. announced it has received notice that on January 29, 2018 the United States District Court for the Central District of California has issued an order dismissing, with prejudice, a putative class-action lawsuit against the company. The dismissal relates to an action brought on November 8, 2016 by a purported shareholder of the Company (Case No. 2:16-cv-08295-ODW) against the Company and two individual defendants: Eric Steen, the Company's former Chief Executive Officer, President and Director; and Jonathan Foster, the Company's former Chief Financial Officer. The complaint asserted claims against all defendants under the antifraud provisions of the federal securities laws and against Messrs. Steen and Foster as control persons. On June 19, 2017, the Company and all defendants filed a Motion to Dismiss the amended complaint. On December 15, 2017, the Court dismissed the plaintiff's first amendment to the class action compliant, with leave to amend. On December 20, 2017, the parties stipulated, and the Court extended, the plaintiff's time to amend the FAC up to January 19, 2018. As of January 19, 2018, the plaintiff never filed an amended complaint and the Court dismissed the lawsuit with prejudice on January 29, 2018.

InfuSystem Holdings, Inc. Appoints Richard Dilorio as President and Chief Executive Officer

InfuSystem Holdings Inc. announced the appointment of Richard DiIorio as President and Chief Executive Officer, effective November 15, 2017. Mr. DiIorio has been elected to serve on the company's Board of Directors. With Mr. DiIorio's appointment, the Office of the President will cease to operate. Mr. DiIorio brings a strong track record of accomplishment with more than seventeen years of medical sales experience, extensive expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Mr. DiIorio has served as a member of the Company's Office of the President since May 2017 and as General Manager of Oncology since December 2016.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

June 19, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact InfuSystem Holdings Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at